The hearing is set for July 19, 2022, to discuss ongoing litigation where San Francisco is suing multiple pharmaceutical companies over issues related to opioid distribution. This public meeting will allow residents to learn more about the case and its implications for the city.
Hearing of the Board of Supervisors sitting as a Committee of the Whole on Tuesday, July 19, 2022, at 3:00 p.m., to hold a public hearing regarding the following existing litigation in which the City is a plaintiff: The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; scheduled pursuant to the Motion contained in File No. 220816, to be considered on July 19, 2022.
How it got here
The motion schedules a public hearing for the Board of Supervisors to discuss a proposed settlement related to a lawsuit against various opioid manufacturers and distributors. It also includes a closed session for the Board to consult with the City Attorney about the ongoing litigation.
This legislation allows the San Francisco Board of Supervisors to hold a closed session to discuss legal strategies with the City Attorney regarding ongoing litigation against several pharmaceutical companies related to the opioid crisis. The session is scheduled for July 19, 2022, in accordance with state and local laws.
This legislation allows the San Francisco Board of Supervisors to hold a closed session to discuss legal strategies with the City Attorney regarding ongoing litigation against several pharmaceutical companies related to the opioid crisis. The session is scheduled for July 19, 2022, in accordance with state and local laws.
The motion schedules a public hearing for the Board of Supervisors to discuss a proposed settlement related to a lawsuit against various opioid manufacturers and distributors. It also includes a closed session for the Board to consult with the City Attorney about the ongoing litigation.